Last update:
Medications news
Medications
Weekly injection offers steady Parkinson's medication, reducing need for daily pills
A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets.
2 hours ago
0
0
Medications
FDA publishes full texts of response letters to drug applications
The U.S. Food and Drug Administration has published more than 200 complete response letters, or decision letters, sent as replies to drug and biological product applications submitted to the agency from 2020 to 2024.
2 hours ago
0
0
An FDA-approved drug halts Epstein-Barr virus-driven lymphoma by disrupting a key cancer pathway
Scientists at The Wistar Institute have discovered that a class of FDA-approved cancer drugs known as PARP1 inhibitors can effectively combat Epstein-Barr virus (EBV)-driven lymphomas. The findings, published in the Journal ...
15 hours ago
0
25
Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks
Receiving six or more prescriptions of the drug gabapentin for low back pain is associated with significantly increased risks of developing dementia and mild cognitive impairment (MCI)—29% and 85%, respectively—finds ...
14 hours ago
0
80
Prescription weight-loss medication linked to disordered eating behaviors in boys and men
As the popularity of medications for weight loss, such as Ozempic and Wegovy, surges across North America, new research raises important concerns about their use among adolescent boys and young men.
18 hours ago
0
0
Cannabinoid products may reduce total sleep time in adults with insomnia says new study
You might have heard cannabis and cannabinoid products can help people sleep. Data shows one of the top reasons people use cannabis is to help them sleep.
23 hours ago
0
1
Does Australia really take too long to approve medicines, as the US says?
Australia's drug approval system is under fire, with critics in the United States claiming it is too slow to approve life-saving medicines.
23 hours ago
0
0
Largest review of antidepressants to date finds most people do not experience severe withdrawal
The largest review of "gold standard" antidepressant withdrawal studies to date has identified the type and incidence of symptoms experienced by people discontinuing antidepressants, finding most people do not experience ...
Jul 9, 2025
0
60
Clinical trials reveal promising alternatives to high-toxicity tuberculosis drug
The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with the potential to replace this current cornerstone in the treatment of drug-resistant ...
Jul 9, 2025
0
21
New compound shows promise in preventing premature births in mice
After nearly 15 years' research, scientists at the UdeM-affiliated CHU Sainte-Justine have developed a compound that has shown remarkable potential in preventing prematurity in mice.
Jul 9, 2025
0
0
Which factors affect the success of popular prescription weight loss drugs in individuals?
A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss after taking prescription drugs called glucagon-like peptide-1 receptor agonists (GLP-1RAs), such ...
Jul 9, 2025
0
0
Poorer countries granted access to HIV prevention drug
Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between US pharmaceutical giant Gilead and the Global Fund, the health financing group said Wednesday.
Jul 9, 2025
0
0
'Dimmer switch' drug candidates offer hope for safer nerve pain and ischemic disease treatments
Scientists have discovered novel drug candidates which could ultimately lead to new effective treatments for conditions caused by tissue stress and inflammation, including neuropathic pain and ischemia-reperfusion injury.
Jul 8, 2025
0
11
First infant malaria treatment receives approval: Novartis
The first malaria treatment for newborns and young infants has received approval from Swiss health regulators, with eight African countries poised to roll the drug out rapidly, pharmaceutical giant Novartis said Tuesday.
Jul 8, 2025
0
0
NRTI use linked to risk for primary open-angle glaucoma
Use of nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) is associated with an increased risk for primary open-angle glaucoma (POAG), according to a study published online June 20 in Ophthalmology.
Jul 8, 2025
0
0
Disparities exist in outpatient referrals for opioid use disorder, study finds
Black patients presenting to the emergency department for an opioid overdose are less likely to receive outpatient referrals for opioid use disorder (OUD), according to a study published online in JAMA Network Open.
Jul 8, 2025
0
0
How strong is your weed? Study shows labels often misrepresent potency
Nearly half of cannabis flower products are inaccurately labeled when it comes to potency, with most showing they contain more THC than they really do. Meanwhile, labels on cannabis concentrates like oils and waxes tend to ...
Jul 7, 2025
0
6
Treatment timing is critical to Prozac's impact on mood behaviors
Researchers have found that the timing of when fluoxetine (commonly known by its brand name, Prozac) is administered is vital in determining the impact it has on long-lasting mood behavior and accompanying changes in the ...
Jul 7, 2025
0
0
Review compares efficacy, safety of treatments for hidradenitis suppurativa
The efficacy and safety of currently approved and pipeline medications for moderate-to-severe hidradenitis suppurativa (HS) are compared in a systematic literature review and network meta-analysis published online July 2 ...
Jul 7, 2025
0
1
Biobank data helps explain why some individuals experience more side effects from antidepressants
Researchers at the University of Tartu Institute of Genomics have gained a deeper understanding of why some people are more prone to experiencing side effects when taking antidepressants.
Jul 7, 2025
0
4
A new drug causes nerve tissue to emit light, enabling faster, safer surgery
When surgeons dissect tissue to remove a tumor or make a repair, they must work cautiously, relying on electrophysical monitors and their own anatomical knowledge to avoid cutting nerves, which could complicate the patient's ...
Jul 3, 2025
0
59
Too many medicines, too many hospital visits: Study highlights hidden risk for older adults
Inappropriate polypharmacy—the excessive or unnecessary use of multiple medications—is a major driver of emergency hospital admissions among adults aged 65 and over, according to a new study from the University of Bath ...
Jul 3, 2025
0
22
Rewriting the rulebook on schizophrenia meds: Why it's time to rethink clozapine protocols
The most effective antipsychotic drug for people with treatment-resistant schizophrenia is clozapine. Yet, across the world, it remains underused—largely due to fears about serious side effects and burdensome monitoring ...
Jul 3, 2025
0
0
Combined therapy integrates Chinese herb Astragalus and methotrexate to address drug resistance in autoimmune diseases
Researchers at the School of Chinese Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), have found that combining the active ingredient extracted from the traditional Chinese medicine Astragalus membranaceus ...
Jul 3, 2025
0
0
FDA to revise labeling of ADHD medication to indicate weight loss risk
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity disorder (ADHD) medications, including certain formulations of amphetamine and methylphenidate, to warn ...
Jul 3, 2025
0
0
